Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 2 |
2015 | 2 |
2016 | 3 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Quantifying Preferences in Drug Benefit-Risk Decisions.
Clin Pharmacol Ther. 2019 Nov;106(5):955-959. doi: 10.1002/cpt.1447. Epub 2019 Apr 24.
Clin Pharmacol Ther. 2019.
PMID: 30929257
Literature review of visual representation of the results of benefit-risk assessments of medicinal products.
Hallgreen CE, Mt-Isa S, Lieftucht A, Phillips LD, Hughes D, Talbot S, Asiimwe A, Downey G, Genov G, Hermann R, Noel R, Peters R, Micaleff A, Tzoulaki I, Ashby D; PROTECT Benefit-Risk group.
Hallgreen CE, et al.
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):238-50. doi: 10.1002/pds.3880. Epub 2015 Nov 2.
Pharmacoepidemiol Drug Saf. 2016.
PMID: 26521865
Free article.
Review.
Item in Clipboard
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Mt-Isa S, Hallgreen CE, Wang N, Callréus T, Genov G, Hirsch I, Hobbiger SF, Hockley KS, Luciani D, Phillips LD, Quartey G, Sarac SB, Stoeckert I, Tzoulaki I, Micaleff A, Ashby D; IMI-PROTECT benefit-risk participants.
Mt-Isa S, et al. Among authors: hockley ks.
Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):667-78. doi: 10.1002/pds.3636. Epub 2014 May 13.
Pharmacoepidemiol Drug Saf. 2014.
PMID: 24821575
Review.
Item in Clipboard
Recommendations for benefit-risk assessment methodologies and visual representations.
Hughes D, Waddingham E, Mt-Isa S, Goginsky A, Chan E, Downey GF, Hallgreen CE, Hockley KS, Juhaeri J, Lieftucht A, Metcalf MA, Noel RA, Phillips LD, Ashby D, Micaleff A; PROTECT Benefit-Risk Group.
Hughes D, et al. Among authors: hockley ks.
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):251-62. doi: 10.1002/pds.3958. Epub 2016 Jan 22.
Pharmacoepidemiol Drug Saf. 2016.
PMID: 26800458
Free article.
Item in Clipboard
A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment.
Nixon R, Dierig C, Mt-Isa S, Stöckert I, Tong T, Kuhls S, Hodgson G, Pears J, Waddingham E, Hockley K, Thomson A.
Nixon R, et al. Among authors: hockley k.
Biom J. 2016 Jan;58(1):8-27. doi: 10.1002/bimj.201300248. Epub 2015 Jan 26.
Biom J. 2016.
PMID: 25619173
Item in Clipboard
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.
Hallgreen CE, van den Ham HA, Mt-Isa S, Ashworth S, Hermann R, Hobbiger S, Luciani D, Micaleff A, Thomson A, Wang N, van Staa TP, Downey G, Hirsch I, Hockley K, Juhaeri J, Metcalf M, Mwangi J, Nixon R, Peters R, Stoeckert I, Waddingham E, Tzoulaki I, Ashby D, Wise L.
Hallgreen CE, et al. Among authors: hockley k.
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):974-83. doi: 10.1002/pds.3676. Epub 2014 Jul 5.
Pharmacoepidemiol Drug Saf. 2014.
PMID: 25043919
Free article.
Item in Clipboard
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group.
Marsh K, van Til JA, Molsen-David E, Juhnke C, Hawken N, Oehrlein EM, Choi YC, Duenas A, Greiner W, Haas K, Hiligsmann M, Hockley KS, Ivlev I, Liu F, Ostermann J, Poder T, Poon JL, Muehlbacher A.
Marsh K, et al. Among authors: hockley ks.
Value Health. 2020 Jul;23(7):831-841. doi: 10.1016/j.jval.2019.11.009. Epub 2020 Jul 5.
Value Health. 2020.
PMID: 32762984
Free article.
Item in Clipboard
Cite
Cite